E 150
Pill imprint E 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Nizatidine Images
- Imprint:
-
E 150
- Strength:
- 150 mg
- Color:
- Yellow & White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- corn starch
croscarmellose sodium
povidone k30
magnesium silicate
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0150
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4643 | Physicians Total Care Inc (repackager) |
| 21695-0375 | Rebel Distributors Corp (repackager) |
| 54569-5924 | A S Medication Solutions LLC (repackager) |
| 16590-0741 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Nizatidine resources
- Nizatidine (Wolters Kluwer)
- Nizatidine Solution (Wolters Kluwer)
- nizatidine (Cerner Multum)
- Nizatidine (AHFS DI)
- Nizatidine (FDA)
- Nizatidine Solution (FDA)
- Nizatidine (Wolters Kluwer)
Search Again
